;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Amgen financial update

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Biopharmaceuticals Date announced: 2014-10-17 Note: Amgen said its board declared a 4Q14 dividend of $0.61 per share to be paid on Dec. 5 to shareholders of …

    Published on 10/27/2014
  • Aptose Biosciences financial update

    Aptose Biosciences Inc. (TSX:APS; NASDAQ:APTO), Toronto, Ontario Business: Cancer, Gene/Cell therapy Date announced: 2014-10-21 Note: Aptose began trading on NASDAQ under the symbol "APTO." The stock will continue to …

    Published on 10/27/2014
  • Esperion financial update

    Esperion Therapeutics Inc. (NASDAQ:ESPR), Plymouth, Mich. Business: Endocrine/Metabolic, Cardiovascular Date announced: 2014-10-21 Note: Esperion raised $12.8 million through the sale of 637,500 shares at $20 to cover …

    Published on 10/27/2014
  • HealthCare Royalty Partners financial update

    Healthcare Royalty Partners, Stamford, Conn. Business: Finance Date announced: 2014-10-20 Note: Healthcare Royalty Partners closed its third fund, Healthcare Royalty Partners III, at $1.5 billion. The firm said the fund…

    Published on 10/27/2014
  • Nuvilex financial update

    Nuvilex Inc. (OTCQB:NVLX), Silver Spring, Md. Business: Cancer, Gene/Cell therapy Date announced: 2014-10-17 Note: Nuvilex filed a shelf registration covering the sale of up to $50 million of its securities. The company…

    Published on 10/27/2014
  • PureTech Ventures financial update

    PureTech Ventures, Boston, Mass. Business: Finance Date announced: 2014-10-20 Note: PureTech Ventures raised $55 million from Invesco Perpetual and other investors, including endowments, angels and pharma companies. The…

    Published on 10/27/2014
  • Tetraphase financial update

    Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Business: Infectious Date announced: 2014-10-22 Note: Tetraphase raised $11.3 million through the sale of 592,500 shares at $19 to cover the overallotment …

    Published on 10/27/2014
  • Zymeworks financial update

    Zymeworks Inc., Vancouver, B.C. Business: Computational chemistry/biology, Antibodies Date announced: 2014-10-21 Note: Zymeworks raised $4.3 million in the third close of a venture round, bringing the total raised in …

    Published on 10/27/2014
  • Molecular Partners postpones IPO

    Molecular Partners AG, Schlieren, Switzerland Business: Ophthalmic, Cancer, Inflammation Date announced: 2014-10-21 Type: IPO Underwriters: JPMorgan; UBS; Cowen; Bank am Bellevue Note: Molecular Partners postponed its …

    Published on 10/27/2014
  • Angion withdraws IPO

    Angion Biomedica Corp., Uniondale, N.Y. Business: Renal, Pulmonary Date announced: 2014-10-24 Type: IPO Underwriter: Aegis Capital Note: Angion Biomedica withdrew its IPO on NASDAQ, citing market conditions.

    Published on 10/27/2014
  • Viamet withdraws IPO

    Viamet Pharmaceuticals Inc., Durham, N.C. Business: Infectious, Cancer Date announced: 2014-10-20 Type: IPO Underwriters: Piper Jaffray; Stifel, Nicolaus; Wells Fargo Note: The company withdrew its proposed IPO on …

    Published on 10/27/2014
  • Anatara completes IPO

    Anatara Lifesciences Ltd. (ASX:ANR), Brisbane, Australia Business: Gastrointestinal, Infectious, Veterinary Date completed: 2014-10-07 Type: IPO Raised: A$7 million ($6.1 million) Shares: 14 million Price: A$0.50 Shares…

    Published on 10/20/2014
  • Astute completes venture financing

    Astute Medical Inc., San Diego, Calif. Business: Diagnostic Date completed: 2014-10-09 Type: Venture financing Raised: Not disclosed Investor: CRG Note: The company received an undisclosed portion of a $30 million loan.…

    Published on 10/20/2014
  • Atara Biotherapeutics completes IPO

    Atara Biotherapeutics Inc. (NASDAQ:ATRA), Brisbane, Calif. Business: Cancer, Renal Date completed: 2014-10-15 Type: IPO Raised: $55 million Shares: 5 million Price: $11 Shares after offering: 19.4 million Underwriters: …

    Published on 10/20/2014
  • Bicycle Therapeutics completes venture financing

    Bicycle Therapeutics Ltd., Cambridge, U.K. Business: Chemistry, Cancer, Ophthalmic Date completed: 2014-10-14 Type: Venture financing Raised: Not disclosed Investors: Atlas Ventures; Novartis Venture Funds; SR One; SV …

    Published on 10/20/2014
  • ContraVir Pharmaceuticals completes private placement of convertible preferred stock

    ContraVir Pharmaceuticals Inc. (OTCBB:CTRV), New York, N.Y. Business: Infectious Date completed: 2014-10-15 Type: Private placement of convertible preferred stock Raised: $9 million Shares: 900,000 Price: $10 Shares …

    Published on 10/20/2014
  • Cytori completes direct public offering

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. Business: Gene/Cell therapy, Musculoskeletal Date completed: 2014-10-10 Type: Direct public offering Raised: $13.5 million Units: 13,500 Price: $1,…

    Published on 10/20/2014
  • DiaGenic completes private placement

    DiaGenic ASA (OSE:DIAG), Oslo, Norway Business: Diagnostic Date completed: 2014-10-10 Type: Private placement Raised: NOK35 million ($5.4 million) Shares: 53.8 million Price: NOK0.65 Shares after offering: 285.1 million

    Published on 10/20/2014
  • DNAtrix completes venture financing

    DNAtrix Inc., Houston, Texas Business: Cancer Date completed: 2014-10-14 Type: Venture financing Raised: $20 million Investors: Morningside Group; Mercury Fund; Targeted Technology Fund; and other investors

    Published on 10/20/2014
  • Esperion completes follow-on

    Esperion Therapeutics Inc. (NASDAQ:ESPR), Plymouth, Mich. Business: Endocrine/Metabolic, Cardiovascular Date completed: 2014-10-15 Type: Follow-on Raised: $85 million Shares: 4.3 million Price: $20 Shares after offering…

    Published on 10/20/2014
  • Forward Pharma completes IPO

    Forward Pharma A/S (NASDAQ:FWP), Copenhagen, Denmark Business: Autoimmune Date completed: 2014-10-15 Type: IPO Raised: $220.5 million Shares: 10.5 million Price: $21 Shares after offering: 45.8 million Underwriters: …

    Published on 10/20/2014
  • Highland Therapeutics completes venture financing

    Highland Therapeutics Inc., Toronto, Ontario Business: Drug delivery Date completed: 2014-10-16 Type: Venture financing Raised: $25 million Investor: Not disclosed Note: The company said it sold class A common shares in…

    Published on 10/20/2014
  • Invitae completes venture financing

    Invitae Corp., San Francisco, Calif. Business: Diagnostic Date completed: 2014-10-13 Type: Venture financing Raised: $120 million Placement agent: JPMorgan Investors: Decheng Capital; Deerfield Management; OrbiMed …

    Published on 10/20/2014
  • Portal Instruments completes venture financing

    Portal Instruments Inc., Cambridge, Mass. Business: Drug delivery Date completed: 2014-10-15 Type: Venture financing Raised: $11 million Investors: Sanofi; PBJ Capital; and an undisclosed investor

    Published on 10/20/2014
  • Raze Therapeutics completes venture financing

    Raze Therapeutics Inc., Cambridge, Mass. Business: Cancer Date completed: 2014-10-14 Type: Venture financing Raised: $24 million Investors: Atlas Ventures; MPM Capital; MS Ventures; Partners Innovation Fund; Astellas …

    Published on 10/20/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993